![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SLC31A2 |
Gene summary for SLC31A2 |
![]() |
Gene information | Species | Human | Gene symbol | SLC31A2 | Gene ID | 1318 |
Gene name | solute carrier family 31 member 2 | |
Gene Alias | COPT2 | |
Cytomap | 9q32 | |
Gene Type | protein-coding | GO ID | GO:0000041 | UniProtAcc | O15432 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
1318 | SLC31A2 | P80T-E | Human | Esophagus | ESCC | 9.43e-10 | 4.12e-01 | 0.155 |
1318 | SLC31A2 | P82T-E | Human | Esophagus | ESCC | 2.13e-04 | 4.27e-01 | 0.1072 |
1318 | SLC31A2 | P83T-E | Human | Esophagus | ESCC | 9.45e-21 | 1.01e+00 | 0.1738 |
1318 | SLC31A2 | P91T-E | Human | Esophagus | ESCC | 2.81e-14 | 1.19e+00 | 0.1828 |
1318 | SLC31A2 | P107T-E | Human | Esophagus | ESCC | 1.42e-56 | 1.77e+00 | 0.171 |
1318 | SLC31A2 | P128T-E | Human | Esophagus | ESCC | 4.90e-04 | 2.48e-01 | 0.1241 |
1318 | SLC31A2 | P130T-E | Human | Esophagus | ESCC | 2.84e-23 | 4.69e-01 | 0.1676 |
1318 | SLC31A2 | C04 | Human | Oral cavity | OSCC | 2.77e-31 | 1.51e+00 | 0.2633 |
1318 | SLC31A2 | C21 | Human | Oral cavity | OSCC | 4.77e-42 | 1.16e+00 | 0.2678 |
1318 | SLC31A2 | C30 | Human | Oral cavity | OSCC | 5.48e-55 | 2.31e+00 | 0.3055 |
1318 | SLC31A2 | C43 | Human | Oral cavity | OSCC | 7.51e-09 | 2.36e-01 | 0.1704 |
1318 | SLC31A2 | C46 | Human | Oral cavity | OSCC | 1.76e-04 | 2.22e-01 | 0.1673 |
1318 | SLC31A2 | C51 | Human | Oral cavity | OSCC | 1.85e-24 | 1.10e+00 | 0.2674 |
1318 | SLC31A2 | C57 | Human | Oral cavity | OSCC | 1.09e-05 | 2.45e-01 | 0.1679 |
1318 | SLC31A2 | C06 | Human | Oral cavity | OSCC | 2.31e-12 | 1.93e+00 | 0.2699 |
1318 | SLC31A2 | C07 | Human | Oral cavity | OSCC | 3.05e-02 | 5.69e-01 | 0.2491 |
1318 | SLC31A2 | C08 | Human | Oral cavity | OSCC | 3.29e-02 | 1.33e-01 | 0.1919 |
1318 | SLC31A2 | LN46 | Human | Oral cavity | OSCC | 2.77e-03 | 2.04e-01 | 0.1666 |
1318 | SLC31A2 | SYSMH2 | Human | Oral cavity | OSCC | 1.52e-16 | 4.25e-01 | 0.2326 |
1318 | SLC31A2 | SYSMH3 | Human | Oral cavity | OSCC | 1.16e-36 | 6.95e-01 | 0.2442 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:005507617 | Esophagus | ESCC | transition metal ion homeostasis | 87/8552 | 138/18723 | 2.85e-05 | 2.37e-04 | 87 |
GO:00469169 | Esophagus | ESCC | cellular transition metal ion homeostasis | 70/8552 | 115/18723 | 7.28e-04 | 3.79e-03 | 70 |
GO:00550703 | Esophagus | ESCC | copper ion homeostasis | 15/8552 | 18/18723 | 1.20e-03 | 5.88e-03 | 15 |
GO:00068781 | Esophagus | ESCC | cellular copper ion homeostasis | 12/8552 | 15/18723 | 7.31e-03 | 2.63e-02 | 12 |
GO:005507610 | Oral cavity | OSCC | transition metal ion homeostasis | 81/7305 | 138/18723 | 2.13e-06 | 2.72e-05 | 81 |
GO:00469168 | Oral cavity | OSCC | cellular transition metal ion homeostasis | 64/7305 | 115/18723 | 2.13e-04 | 1.40e-03 | 64 |
GO:00550702 | Oral cavity | OSCC | copper ion homeostasis | 14/7305 | 18/18723 | 9.51e-04 | 4.96e-03 | 14 |
GO:0006878 | Oral cavity | OSCC | cellular copper ion homeostasis | 11/7305 | 15/18723 | 7.49e-03 | 2.75e-02 | 11 |
GO:005507618 | Skin | cSCC | transition metal ion homeostasis | 57/4864 | 138/18723 | 5.96e-05 | 5.86e-04 | 57 |
GO:004691610 | Skin | cSCC | cellular transition metal ion homeostasis | 48/4864 | 115/18723 | 1.63e-04 | 1.43e-03 | 48 |
GO:00550704 | Skin | cSCC | copper ion homeostasis | 12/4864 | 18/18723 | 3.39e-04 | 2.68e-03 | 12 |
GO:00068782 | Skin | cSCC | cellular copper ion homeostasis | 10/4864 | 15/18723 | 1.10e-03 | 7.24e-03 | 10 |
GO:005507632 | Thyroid | ATC | transition metal ion homeostasis | 66/6293 | 138/18723 | 3.64e-04 | 2.25e-03 | 66 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SLC31A2 | SNV | Missense_Mutation | novel | c.389N>T | p.Ala130Val | p.A130V | O15432 | protein_coding | tolerated(0.22) | benign(0.281) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
SLC31A2 | SNV | Missense_Mutation | novel | c.89T>C | p.Val30Ala | p.V30A | O15432 | protein_coding | deleterious(0.02) | probably_damaging(0.932) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SLC31A2 | SNV | Missense_Mutation | c.215N>T | p.Gly72Val | p.G72V | O15432 | protein_coding | tolerated(0.28) | benign(0.096) | TCGA-D1-A15X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
SLC31A2 | SNV | Missense_Mutation | novel | c.221C>A | p.Ser74Tyr | p.S74Y | O15432 | protein_coding | deleterious(0.01) | probably_damaging(0.989) | TCGA-DJ-A2QB-01 | Thyroid | thyroid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SLC31A2 | SNV | Missense_Mutation | novel | c.207N>C | p.Glu69Asp | p.E69D | O15432 | protein_coding | tolerated(0.17) | benign(0.01) | TCGA-ET-A2N3-01 | Thyroid | thyroid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |